Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLORY-YOUNG
CTR20254559Phase 3Active
- Sponsor
- InnoCare Pharma
- Start
- Dec 2025
- Modality
- Hormonal Peptides → Native Peptides → Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of mazdutide in obesity, Overweight, sponsored by InnoCare Pharma. Started Dec 2025; status: active.
02
Drugs
mazdutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20254559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254559.